CGRP Suppresses Protective SiglecF^hi Neutrophil Development in Neonatal Group B Streptococcus Pneumonia

Area of Science:

• Immunology
• Neonatal Medicine
• Microbiology

Background:

• Neonatal pneumonia, a major cause of infant illness and death, is often caused by Group B Streptococcus (GBS).
• Understanding the immune responses that protect the neonatal lung from GBS is crucial but incomplete.
• Existing knowledge gaps hinder the development of effective treatments for neonatal GBS pneumonia.

Purpose of the Study:

• To investigate the immune mechanisms governing the severity of neonatal Group B Streptococcus pneumonia.
• To explore the role of neutrophil phenotype and the neuroimmune axis in disease progression.
• To identify potential therapeutic targets for improving outcomes in neonatal GBS infections.

Main Methods:

• Utilized a clinically relevant neonatal mouse model of GBS pneumonia.
• Analyzed neutrophil recruitment and phenotype in infected neonatal lungs.
• Quantified bacterial clearance and lung pathology.
• Measured calcitonin gene-related peptide (CGRP) expression and its effect on neutrophil function.

Main Results:

• Neutrophils were recruited to the lungs, but their phenotype varied with disease severity.
• Severe GBS pneumonia was characterized by a lack of SiglecF-high neutrophils, correlating with reduced bacterial clearance and increased pathology.
• Increased lung CGRP expression in severe disease suppressed neutrophil activation, impairing antibacterial function.
• Group B Streptococcus appears to exploit the neuroimmune axis via CGRP to evade host defenses.

Conclusions:

• Neonatal GBS pneumonia severity is linked to neutrophil activation status and CGRP signaling.
• CGRP-mediated suppression of neutrophil function is a key mechanism by which GBS evades host immunity in neonates.
• Targeting the neuroimmune axis, specifically CGRP, may offer a novel therapeutic strategy for neonatal GBS pneumonia.